Aims Patient education for the management of Type 2 diabetes can be delivered in various forms, with the goal of promoting and supporting positive self-management behaviours. This systematic review aimed to determine the effectiveness of group-based interventions compared with individual interventions or usual care for improving clinical, lifestyle and psychosocial outcomes in people with Type 2 diabetes.
Introduction
Patient education is an integral and vital component of successful diabetes care [1] [2] [3] . The main goal of diabetes patient education is to promote and support positive selfmanagement behaviours to optimize metabolic control, improve long-term diabetes outcomes and quality of life (QOL), prevent complications, and reduce morbidity and mortality, while remaining cost-efficient [1, 4] . Group-based education for individuals with Type 2 diabetes may be more cost-effective and efficient than individual education, due to the reduced time and funding required to educate numerous people in one sitting [5] . The potential advantages of groupbased education interventions over individual visits include time for the provision of more detailed information, decreased time demands on health workers, easy incorporation of families and carers, and facilitation of discussions and support from others facing the same challenges [6, 7] . Clearly, the use of group-based education warrants further investigation.
Three previous systematic reviews included group education for Type 2 diabetes. A Cochrane systematic review assessed the effects of group-based training on clinical, lifestyle and psychosocial outcomes in people with Type 2 diabetes compared with routine treatment, waiting list control or no intervention [8] . The review favoured groupCorrespondence to: Kate Odgers-Jewell. E-mail: kodgersj@bond.edu.au ª 2017 Diabetes UK based education, finding significant improvements in HbA 1c levels, body weight, systolic blood pressure (BP), and fasting blood glucose (FBG), a decreased need for diabetes medication and increased diabetes knowledge [8] . A subsequent publication in 2012, updating the original Cochrane review, supported the findings of the former, favouring group-based education, with significant reductions in HbA 1c , FBG and body weight, and improvements in diabetes knowledge compared with controls [6] . Another recent systematic review [9] assessed the effect of diabetes self-management education and support methods, providers, duration and contact time on glycaemic control in adults diagnosed with Type 2 diabetes. The review included individual, groupbased, combination and remote interventions for the management of Type 2 diabetes, with results suggesting that a combination of individual and group-based education was most effective at improving HbA 1c (median 9.6 mmol/mol; 0.88%) when compared with controls [9] .
These previous reviews had limitations. First, the searches are outdated and the number of published studies for groupbased diabetes interventions has increased substantially since their completion. High heterogeneity precluded meta-analyses for several of the main outcomes, which were completed for just two studies [6, 8] . Although both reviews found clinical and statistically significant changes in health outcomes, the exact mechanism or 'active ingredient(s)' of these complex interventions were not identified [6, 8] . Both reviews only conducted follow-up analyses of the primary outcome up to 2 years from baseline [6, 8] . The quality of the previous reviews was assessed using 'A Measurement Tool to Assess Systematic Reviews' (AMSTAR), a reliable and valid method for assessing the methodological quality of systematic reviews [10] . The AMSTAR scores were categorized in line with previous research [11, 12] , with scores of 0-4 classified as 'low quality', 5-8 classified as 'moderate quality', and 9-11 classified as 'high quality'. The Cochrane review [8] was assessed as a highquality review (score: 9/11). This review lacked an assessment of publication bias and conflict of interest for the included studies. The review by Steinsbekk et al. [6] was assessed as a moderate quality review (score: 5/11); no protocol was available, grey literature and publication bias were not considered, a list of excluded studies was not provided, an assessment of conflict of interest for included studies was not explored and the scientific quality of the included studies was not used appropriately in formatting conclusions. The review by Chrvala et al. [9] was assessed as a moderate quality review (score: 7/11); grey literature and publication bias were not considered, a list of excluded studies was not provided and conflict of interest for included studies was not explored. The review had various limitations including: restricting included studies to English-language publications, including only randomized controlled trials, including interventions for individuals with either/both Type 1 and/or Type 2 diabetes, and an inability to conduct meta-analyses [9] .
Despite these systematic reviews providing evidence of effectiveness, group-based education interventions are often complex and the characteristics of the interventions vary greatly, for example, in the number of contact hours, number of sessions, number and characteristics of participants, group facilitator(s) or educator (s) qualifications, facilitator training, theoretical framework, and whether family, friends or carers can attend [6, 8] . Health professionals may deter from groupbased education because the essential attributes for a successful group-based education programme are unknown. Furthermore, no specific evidence-based practice guidelines for group-based education in Type 2 diabetes have been identified internationally, inevitably resulting in wide variations in the programmes offered, and creating difficulty in the interpretation of evidence and its translation to a practice setting.
This systematic review builds upon two of the previous reviews [6, 8] and seeks to update the evidence for the effectiveness of group-based interventions for Type 2 diabetes management and investigate key attributes for successful group programmes. It was hypothesized that: group-based interventions for Type 2 diabetes would have greater reductions in HbA 1c compared with controls in the short (6 months) and long (> 12 months) term; group-based interventions for Type 2 diabetes would improve body weight, body mass index (BMI), waist circumference, FBG, BP, lipid profiles, diabetes knowledge and self-efficacy, compared with controls; variations in effect sizes could be attributed to study design (i.e. setting, control group, educator), and intervention characteristics (i.e. number of participants, intervention length, number of contact hours).
Methods
The study was registered with the International Prospective Register of Systematic Reviews PROSPERO (CRD420150 27785).
What's new?
• We present a comprehensive up-to-date review of the evidence for the effectiveness of Type 2 diabetes groupbased interventions. This is the first review in the area to complete a meta-regression.
• We report statistically significant results for improving HbA 1c , fasting blood glucose, body weight, waist circumference, triglycerides and diabetes knowledge, but clinical improvement is more nuanced.
• Group-based interventions facilitated by a single discipline, multidisciplinary teams or health professionals with peer supporters appear to be more effective at improving HbA 1c than peer-led interventions.
Data sources and search strategy
A systematic literature search was performed to retrieve publications on group-based education for the management of Type 2 diabetes in adults. The search was completed in three parts. First, electronic databases, including PubMed, the Cochrane Central Register of Controlled Trials (CEN-TRAL), Embase, CINAHL, PsycINFO and ERIC, were searched from commencement of records to 22 September 2015 (File S1). Second, hand searches of reference lists from previous reviews were completed [6, 8] . Finally, the included studies were cross-referenced with the results of an updated search by the authors of the most recent review including studies up to May 2012 (email correspondence). No language or date restrictions were applied. Abstract-only publications were excluded and duplicate articles were removed prior to title and abstract screening.
Inclusion criteria and study selection
Group-based education intervention studies for participants diagnosed with Type 2 diabetes that reported randomized controlled trials, cluster randomized trial or controlled clinical trial study designs were included. Studies were included if the described intervention met the following criteria: adults aged ≥ 18 years; face-to-face, educative group-based interventions (including those with occasional adjunct individual consultations) for people with Type 2 diabetes; a minimum of four participants and may include family and friends for support; a minimum of one session lasting for 1 h; groups delivered in primary or secondary care compared with a control or comparison group (usual care, waiting list control or individual intervention); and studies that measured HbA 1c at both baseline and 6 or more months from baseline. Studies were excluded if participants were pregnant women or were diagnosed with Type 1 diabetes, or interventions provided education in individual consultations, included only exercise prescriptions without education or were not conducted face-to-face. All studies were screened against the eligibility criteria by two independent reviewers (KOJ and LEB) using reference manager software EndNote (Thomson Reuters, New York, NY, USA). Conflicts were resolved by discussion between them. Studies that met the inclusion criteria or did not include sufficient information for screening in the title and abstract, were included for full-text review. Full-text versions of these articles were obtained and screened independently. Authors were contacted for missing data up to three times by email if the missing data affected assessment of the study's eligibility, and were excluded if contact could not be made.
Data extraction and quality assessment Data extraction was completed by the first author (KOJ) and confirmed for accuracy by an independent reviewer (JTK).
Data extracted included: general information on the study design, trial characteristics, intervention details, participant characteristics, outcome measures, results and information for appraising the risk of bias. Study quality was assessed using the Cochrane risk of bias tool [13] by two independent reviewers (KOJ and LEB). Disagreements were resolved through discussion. Risk of bias was ranked as low, unclear or high depending on whether a study had any element of bias (e.g. selection, performance, detection, attrition, reporting and other bias).
Data synthesis and analysis
Descriptive data from the included studies were summarized. Data were meta-analysed if the same measurement was used across three or more studies at the same time point. The primary outcome measure was change in HbA 1c in groupbased education vs. control. The secondary outcome measures were changes in FBG, weight, BMI, waist circumference, BP, total cholesterol, LDL-cholesterol, HDLcholesterol, triglycerides, diabetes knowledge and self-efficacy. Prior to the meta-analyses, studies reporting FBG or lipid profile measures in mg/dl were converted to mmol/l; those reporting weight in lb were converted to kg.
Summaries of effect estimates were calculated by metaanalysis using the DerSimonian and Laird random effects model in Review Manager (RevMan, v. 5.3) [14] . Continuous data using the same measures were analysed with a weighted mean difference in outcomes between the intervention and control groups, whereas continuous data collected using a variety of measures were assessed using the standard mean difference (SMD). Heterogeneity was assessed using the I-squared statistic and reported following the Cochrane Handbook [13] .
Mean differences (MD) and 95% confidence intervals (CI) were calculated in RevMan and standard error was calculated in Microsoft â Excel using the 95% CIs for the metaregression. Separate analyses for the effect of group-based interventions on HbA 1c were performed for the following subgroups: control groups, delivery setting, insulin therapy, type of educator(s), training of educator(s), baseline HbA 1c levels, theoretical model and intervention content, materials, length, number of sessions, contact time, number of participants and the inclusion/exclusion of family and/or friends. Sensitivity analyses were conducted to explore the influence of study quality (overall risk of bias and reporting bias), on HbA 1c outcomes (as measured closest to intervention completion) and heterogeneity. Reporting bias and selective outcome reporting were chosen for the sensitivity analysis because studies that did not report the pre-specified outcomes or failed to include the results for an expected outcome may be reporting only results supporting the studies' aims or hypotheses. We also examined potential influences on the primary outcome for studies that had differences in HbA 1c at baseline, large (defined as > 10%) compared with small attrition (defined as < 10%), and studies published in nonEnglish journals due to potential publication bias.
Subgroup analyses were also conducted to examine the effects of different educators (health professionals, health professionals with peer support, peer or lay-persons), disciplines (single discipline compared with multidiscipline) and studies that included participants taking (and not taking) insulin on the primary outcome HbA 1c .
In addition, a univariate meta-regression was completed to explore potential associations between the size of effect and varying study and intervention characteristics [15] . Variables were similar to those explored in the subgroup analyses. A meta-regression was performed using Stata statistical software [16] .
Results

Study selection
The search identified 14 016 results, from which 9764 publications were screened against the selection criteria, leaving 298 studies for full-text review ( Fig. 1) . Forty-seven studies reported in 53 publications were included in the systematic review (references provided in File S2).
A total of 8533 participants were included in the 47 studies (intervention group n = 4416, control group n = 4117). The mean age of participants was 60 years. Men made up 44% of participants in both the intervention (1917 of 4383) and control (1799 of 4086) groups. Three of the 47 included studies (6%) recruited only women. Known duration of diabetes was reported by 29 of the 47 studies (62%). Mean duration of diabetes was 8.9 years for participants in the intervention group, and 9.4 years in the control group. Mean HbA 1c level at baseline was 67 mmol/mol (8.3%) for both groups and ranged between 39 and 111 mmol/mol (5.7%-12.3%) for the intervention group and between 40 and 115 mmol/mol (5.8%-12.7%) for the control group. In 38 (81%) studies, the mean HbA 1c was > 53 mmol/mol (7%) for both the intervention and control groups.
Study characteristics
Study characteristics are detailed in Table S1 . Of the 47 studies included, 40 reported the results of randomized controlled trials, four reported results of controlled clinical trials and three reported the results of cluster randomized controlled trials. Most of the studies were carried out in the USA (18; 38%), the UK (6; 13%) and Italy (5; 11%). Fortytwo of the studies were published in English, two in Spanish [17, 18] , two in Italian [19, 20] and one in Dutch [21] . The studies were published between 1988 and 2015, and the length of follow-up was 6-60 months from baseline. 
FIGURE 1 Stages of study identification
Intervention characteristics varied in materials provided, discipline(s) of group educators and theoretical model used, as summarized in Table S2 . Studies were conducted predominantly in primary care settings (32; 68%), with 15 (32%) of the studies delivered in secondary or tertiary care settings, for example, hospital diabetes centres or tertiary hospitals. Four publications [22] [23] [24] [25] reported on multiple arm studies.
Study quality
Most studies were classified as having a moderate (31) or high (12) risk of bias, with four studies classified as having a low risk of bias (Table S3 ). Of the six risk of bias items, allocation concealment (selection bias), blinding of participants and personnel (performance bias), and blinding of outcome assessment (detection bias) were the least consistently described or were generally poorly conducted in the included studies (Fig. S1 ).
Overall effects of group-based interventions for HbA 1c
A meta-analysis was conducted to assess the effect of groupbased education compared with control for all 47 included studies (n = 7055) using the measure of HbA 1c at the time point closest to the completion of each group-based education intervention (Fig. 2) . Overall, compared with control, group-based intervention was effective in reducing HbA 1c by 4 mmol/mol (0.3%) (95% CI: À0.51, À0.17; P < 0.0001; I 2 = 84%). Heterogeneity was statistically significant and potential reasons for this were explored with sensitivity analyses.
The results of the meta-analyses for HbA 1c and secondary outcome measures at various time points are provided in Table 1 .
Group-based interventions significantly reduced HbA 1c post intervention at most time points compared with controls. HbA 1c was significantly reduced at 6-10 months post baseline [n = 30 studies; MD = 3 mmol/mol (0.3%); 95% CI: À0. 48 when eight studies comparing group-based interventions with controls measured HbA 1c at 24 months post baseline, there was no significant difference between the groups. This time point also had the highest heterogeneity (I 2 = 94%).
There was variation in effectiveness in reducing FBG when comparing group-based interventions with controls. Groupbased education was significantly more effective at reducing FBG compared with controls at 12-14 months post baseline (n = 8 studies; MD = 0.68 mmol/l; 95% CI: À1.25, À0.11; P = 0.02; I 2 = 55%). However, this was not the case for FBG when measured at 6-10 or 24 months post baseline. All time points were assessed as having significant heterogeneity. Group-based education was significantly more effective at reducing body weight compared with controls at both 6-10 months (n = 17 studies; MD = 1.22 kg; 95% CI: À2.22, À0.23; P = 0.02; I 2 = 62%) and 12-14 months (n = 9 studies; MD = 1.43 kg; 95% CI: À2.09, À0.77; P < 0.0001; I 2 = 0%). Despite the statistically significant improvements in body weight at two time points, groupbased education was not effective at significantly reducing BMI. Group-based education was significantly more effective at reducing waist circumference at 6-10 months (n = 5 studies; MD = 1.19 cm; 95% CI: À2.34, À0.05; P = 0.04; I 2 = 58%) than controls. However, although waist circumference showed a trend for improvement with group-based education at 12-14 months, the difference between groups was not significant (n = 3 studies; MD = 0.79 cm; 95% CI: À1.96, 0.38; P = 0.19; I 2 = 38%).
Both systolic and diastolic BP were measured at four time points (6-10, 12-14, 24 and 36-48 months post baseline). When pooled, changes in systolic and diastolic BP were not statistically different between groups for any of these intervals. In addition, there were no significant differences in total cholesterol between group-based interventions and controls at any time point.
There were no statistically significant differences in HDLcholesterol between groups at any time point. Heterogeneity was significant at all time points. There were mixed results for LDL-cholesterol when measured at two time points, 6-10 and 12-14 months (Table 1) . At 6-10 months, the meta-analysis resulted in no significant differences between groups for LDL-cholesterol (n = 12 studies; MD = 0.03 mmol/l; 95% CI: À0.13, 0.07; P = 0.59; I 2 = 49%). The studies assessing LDL-cholesterol at 12-14 months showed a significant decrease in LDL favouring the control group (n = 5 studies; MD = 0.08 mmol/l; 95% CI: 0.01, 0.15; P = 0.04; I 2 = 0%). Group-based education was significantly more effective at reducing triglycerides at 6-10 months (n = 14 studies; MD = 0.13 mmol/l; 95% CI: À0.24, À0.01; P = 0.03; I 2 = 4%) and 24 months (n = 3 studies; MD = 0.32 mmol/l; 95% CI: À0.58, À0.06; P = 0.01; I 2 = 8%). At 12-14 months, the difference between groups for triglycerides were not significant (n = 11 studies; MD = 0.04; 95% CI: À0.22, 0.14; P = 0.66; I 2 = 68%).
Diabetes knowledge was reported by 16 studies and measured using a range of validated questionnaires. Groupbased education was significantly associated with improved diabetes knowledge at two time points: 6-10 months (n = 7 studies; SMD = 0.61; 95% CI: 0.14, 1.08; P = 0.01; I 2 = 83%) and 12-14 months (n = 7 studies; SMD = 0.58; 95% CI: 0.08, 0.97; P = 0.02; I 2 = 93%). Self-efficacy was reported by five studies at three time points (6, 12 and 24 months). Group-based education showed a trend to improved self-efficacy at 12 months post baseline (n = 3 ª 2017 Diabetes UK studies; SMD = 0.15; 95% CI: À0.02, 0.33; P = 0.08; I 2 = 0%), however, these measures were not significant. In addition, QOL, depression, energy intake and physical activity levels were assessed (Table S4) .
Subgroup analyses
Analyses were completed for 13 subgroups using HbA 1c at the point closest to the end of each of the group-based education interventions as the outcome measure ( Table 2 ). The type of educator subgroup analysis resulted in a significant subgroup difference (P = 0.002), with peer-and/ or lay-led group-based interventions having no significant influence on improving HbA 1c (P = 0.80). Interventions facilitated by single disciplines (P = 0.0003), multidisciplinary teams (P = 0.02) or health professionals with peer supporters (P = 0.01) were effective at significantly improving HbA 1c (Table 2 and Fig. S2 ). Types of educators were further analysed to individual disciplines included in the 'single discipline' group, finding that physician-, dietitianand nurse-led group-based education interventions were effective (P < 0.00001) at improving HbA 1c (Fig. S3) . Heterogeneity for both subgroup analyses was significant (I 2 = 79.1% and 89.2%, respectively). In addition, subgroup analysis of studies with regards to insulin therapy resulted in a significant subgroup difference (P < 0.00001), with interventions that excluded participants on insulin therapy resulting in greater reductions in HbA 1c (Fig. S4) . Heterogeneity for both subgroup analyses was significant (I 2 = 69% and 88%, respectively). 
Sensitivity analyses
Sensitivity analyses were performed to explore the influence of study quality and characteristics on post-baseline HbA 1c outcomes (Table 3 ) and heterogeneity. Forest plots for sensitivity analyses are reported in Figs S5-S9. There were no significant differences in HbA 1c outcomes when study quality and attrition were explored; all subgroups showed statistically significant improvements in HbA 1c (P ≤ 0.05). However, subgroups of studies assessed as being at high risk of reporting bias (Fig. S6) , having baseline differences between groups (Fig. S7 ) and studies published in non-English journals (Fig. S9) did not show significant improvements in HbA 1c .
Meta-regression
We used study variables and intervention characteristics including theoretical model, discipline(s) of educator(s), educator training, materials provided, delivery in primary care, both groups HbA 1c < 7% at baseline, intervention length, contact time, number of participants, number of sessions, and the inclusion of family and friends in a metaregression to explore potential associations between the size of effect and study and intervention characteristics on HbA 1c at post intervention. None of these variables explained significant portions of heterogeneity among the studies (Table S5) . 2008 [6] . This study fills this important gap and attempted to expand our understanding of effective intervention components. Meta-analyses of the primary outcome measure, HbA 1c , resulted in statistically significant improvements at 6-10, 12-14, 18 and 36-48 months, but unexpectedly, not at 24 months post intervention. The meta-analysis at this time point had the highest heterogeneity (I 2 = 94%). One study [26] , in which contact with intervention participants decreased after 6 months, favoured the control group and appeared to be an outlier, with a mean difference increase in HbA 1c of 0.60% (95% CI: 0.52, 0.68). When this, and three other studies [18, 20, 27 ] assessed as high risk, were excluded from the meta-analysis, heterogeneity decreased substantially (I 2 = 0%) and HbA 1c lowered in favour of the intervention group [n = 4 studies; MD = 6 mmol/mol (0.6%); 95% CI: À0.86, À0.32; P < 0.0001] at the 24-month time point. Statistically significant reductions ranged from 3 mmol/mol (0.3%) at 6-10 months when pooled for 30 studies to 10 mmol/mol (0.9%) at 36-48 months when pooled for five studies. Although these reductions did not reach 11 mmol/ mol (1%), suggested as the level necessary to achieve clinical importance [28, 29] , similar-sized reductions in HbA 1c are known to mediate the risk of Type 2 diabetes complications [30] . Variability in outcomes was found for some secondary outcome measures, specifically FBG, body weight, waist circumference, triglyceride levels and diabetes knowledge. For example, FBG was improved statistically by mean reductions of 0.68 mmol/l at 12-14 months, but not at other time points. Previous research suggests that improving FBG in people with Type 2 diabetes can reduce the development or progression of microvascular complications and can improve QOL [31] . Ideally, FBG should be maintained < 7.2 mmol/l in individuals with Type 2 diabetes [32] .
Although the data suggest statistical improvements, only two of the eight studies included in the meta-analysis of FBG at 12-14 months resulted in reductions of FBG to < 7.2 mmol/l, suggesting that the improvements in FBG may be less clinically important. This may indicate that group-based education programmes are not effective at improving various secondary outcome measures when compared with controls, or that further consideration of these measures is required.
Body weight and waist circumference were statistically improved by group-based interventions at time points closer to intervention completion, indicating that interventions were effective at improving these measures; however, maintenance of these improvements requires further consideration. Weight control is recognized as a central strategy in diabetes care [31] , however, the reductions in body weight (range 0.62-1.43 kg) and waist circumference (range 0.79-1.19 cm) in this review are unlikely to be clinically important. It has been demonstrated that a sustained weight loss (> 12 months) of 5 kg in people with Type 2 diabetes is associated with a reduction in HbA 1c of 6-11 mmol/mol (0.5%-1%) [33] . Furthermore, for overweight or obese individuals with Type 2 diabetes, a weight loss of at least 5% seems necessary to improve blood glucose, lipid profiles and blood pressure [34] . However, it is unclear whether the participants in the included studies were overweight or obese, and a recent study found that intensive lifestyle interventions focusing on weight loss in adults with Type 2 diabetes did not reduce the rate of cardiovascular events despite significant weight loss [35] . Waist circumference is a commonly utilized measure of total body fat, a useful predictor of visceral fat [36] , and can be a better predictor of cardiovascular risk [37] than BMI. It is likely that the reductions in weight were not great enough to influence BMI measures. These results are in line with previous systematic ª 2017 Diabetes UK reviews, which found no statistically significant differences in BMI between groups [6, 8] .
Despite improvement in various blood lipid (excepting LDL-cholesterol) and BP measures, statistical significance was not reached at most time points. There may be several reasons for this: the limited number of studies assessing or providing education on these measures, the lack of intervention focus on blood lipids or BP, the widespread and early use of pharmacological interventions, the inclusion of participants on cholesterol-reducing or hypotensive medications, and underpowered studies to detect changes in blood lipids or BP. The results highlight an important area for future research, given that improvements in lipid measures and BP control in Type 2 diabetes can reduce the risk of death related to diabetes, macrovascular and microvascular complications and myocardial infarction [29] .
The meta-analyses indicate that group-based interventions are effective at improving diabetes knowledge, but no differences in self-efficacy were evident. Perceived selfefficacy describes a person's confidence or belief about his or her personal capabilities to accomplish a task or change a behaviour [38] . The found improvement in diabetes knowledge is consistent with two previous systematic reviews [6, 8] . Successful self-management of Type 2 diabetes requires sufficient knowledge of the condition and its treatment, and the performance of self-management activities and skills [39] , and knowledge is an essential prerequisite [1] .
The subgroup analyses revealed that peer-or lay-led group-based interventions did not significantly reduce HbA 1c ; however, interventions facilitated by single disciplines, multidisciplinary teams or health professionals with peer supporters resulted in statistical improvements in HbA 1c . Furthermore, subgroup analysis of single educator studies indicated that physician-, dietitian-and nurse-led group-based education interventions were equally effective at improving HbA 1c levels. The International Diabetes Federation guideline recommends that an appropriately trained multidisciplinary team provides education to groups of people with diabetes [40] . It defines limited care as group education by a smaller team, for example, with a physician and diabetes educator or, in very limited situations, an appropriately skilled individual [40] . By contrast, and similar to the previous review [6] , the results of this review indicate that educators from a single discipline providing group-based education to persons with Type 2 diabetes can be more effective than multidisciplinary teams. Multidisciplinary teams may result in reduced contact time with each educator, thus limiting the participant's development of relationships and level of perceived support. Support from group educators can enhance the development of self-management skills in people with Type 2 diabetes [41] [42] [43] , with researchers suggesting that this support can influence an individual's motivation to self-manage their condition [44, 45] .
Our results support the use of peer facilitators complementing health professionals, rather than replacing them [7] .
Peer support can enhance and complement other healthcare services, can provide role-modelling and practical, emotional and ongoing support, and can assist individuals to follow management plans, cope with the stressors of chronic disease and remain motivated [46, 47] . The benefits of peer support include the establishment of a non-hierarchical, reciprocal relationship with the individual, and the ability to share knowledge, life experience and common illness experiences, which many health workers would not have [7] .
Although HbA 1c did improve statistically in both groups as expected, studies that excluded participants that used insulin showed greater improvements in HbA 1c than studies that included them. This was an expected result, because insulin therapy lowers blood glucose and HbA 1c , resulting in tighter glycaemic control [32] .
Despite the lack of statistically significant differences between subgroups, some subgroup analyses resulted in significant improvements, whereas others did not. To improve HbA 1c outcomes for individuals with Type 2 diabetes, the following characteristics of group-based interventions may be associated with greater effects: conducted in primary care settings; provide materials to participants; have < 10 sessions provided either in < 1 month, or over 7-12 or 13-60 months; provide < 8, 8-12, 19-30 or 31 h or more of contact time; include < 20 participants in each group; and include individuals with HbA 1c levels > 53 mmol/mol (7%).
Although not directly comparable because we did not reach a pooled reduction of HbA 1c of 11 mmol/mol (1%), these results differed from the findings from a previous systematic review which found that the only predictor of a reduction in HbA 1c of 11 mmol/mol (1%) was contact time of 23.6 h [4] . Furthermore, a previous systematic review found that groupbased interventions delivered in < 10 months, with > 12 h of contact time over 6-10 sessions were most efficacious in improving HbA 1c [6] . The reasons for the different results relative to the contact time are likely due to other intervention factors, such as intervention content, facilitators or intervention length.
Finally, studies in which the content was facilitatordirected resulted in significant improvements in HbA 1c , whereas patient-directed interventions did not. These results contradict the findings from previous studies, which support the use of a patient-centred approach, suggesting that engaging individuals in their healthcare decisions can enhance their adherence to therapy [32] . Patient-directed interventions, in which participants decide on the content covered in the intervention and can therefore explore their own agenda, interests and needs, have been suggested to be effective in improving participant knowledge, blood glucose levels, weight and medication usage, as well as assisting the development of self-management behaviours [48, 49] . Facilitator-directed programmes contain lesson plans with clearly defined content selected by intervention facilitators. This allows programmes to be replicated by multiple facilitators; however, they may be more likely to utilize a didactic facilitation style, which could reduce time for group interactions and discussion [48] . The subgroup analysis in the current study, however, was underpowered, with only four studies utilizing a patient-centred approach, compared with 43 studies utilizing a facilitator-directed approach. Furthermore, studies that compared group-based interventions to usual care were effective at improving HbA 1c , whereas those compared with other comparators (e.g. individual education, waiting list control), did not significantly improve HbA 1c . However, this analysis did not result in a significant difference between groups, and was underpowered, with 28 (65%) of the studies comparing to usual care controls.
Limitations
Although our study has many strengths, there are several limitations. Using the AMSTAR quality assessment tool, our review is of high quality (10/11). A search of the grey literature in the area was not completed and may have resulted in publication bias. However, we conducted sensitivity analysis to consider the influence of publication bias when studies were published in non-English journals and found no differences in the primary outcome. Most studies included in the review were assessed as having a moderate (31 of 47 studies) or high (12 of 47 studies) risk of bias. As such, the results should be interpreted with caution. Thirteen studies were assessed as having a potential conflict of interest either due to partial funding or equipment donations by pharmaceutical companies, or possible financial gains to the authors from commercially available materials and training courses (Table S1 ). Only 5 of the 47 included studies measured hypoglycaemia, an important end point, unwanted consequence of therapy and commonly feared acute complication in Type 2 diabetes [31] . Furthermore, the authors were unable to explore the barriers and enablers regarding the implementation of education programmes because this information was not commonly provided in published reports.
Numerous meta-analyses resulted in high heterogeneity between studies; however, this is common in allied health research, particularly in complex interventions, and was assessed comprehensively through sensitivity analyses, subgroup analyses and a univariate meta-regression. Furthermore, the two previous systematic reviews also had high heterogeneity, with the Cochrane review reporting I 2 scores between 0% and 96.4% [8] and a review by Steinsbekk et al. [6] reporting I 2 scores between 0% and 85.5%.
Conclusions
The 47 studies included in this systematic review provide evidence supporting the use of group-based education for the management of Type 2 diabetes to significantly improve HbA 1c , FBG, body weight, waist circumference, triglycerides and diabetes knowledge. However, the results may not be clinically important and were complex, with most outcomes improving at time points proximal to the intervention, but others improving at more distal time points. In addition, the results should be interpreted with caution due to the high heterogeneity of some of the meta-analyses, as well as assessment of most of the included studies as having a moderate or high risk of bias. Group-based education interventions facilitated by single disciplines, multidisciplinary teams or health professionals with peer supporters result in improved outcomes in HbA 1c when compared with peer-led interventions. The lack of statistical significance in all but two of the subgroup analyses may indicate that other factors such as peer identification, normalization and group interactions are the 'active ingredient(s)' and, as such, substantially influence the effectiveness of group-based education interventions for the management of Type 2 diabetes. Future research should explore these factors, as well as the cost-effectiveness of, and barriers and facilitators to implementing group-based education programmes for the management of Type 2 diabetes. Finally, future interventions should consider hypoglycaemia as an important end point.
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